Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
The Journal of Clinical and Aesthetic Dermatology|October 24, 2024
Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque PsoriasisJuan Gabriel Vasquez, Jayme M Heim, Tina Bhutani, et al.Journal of the Indian Medical Association|April 23, 2011
Parvovirus B19 serology in early inflammatory polyarthritis--experience from a tertiary core teaching hospital in South IndiaD Danda, Harris V K Naina, Mary Abraham, et al.International Medical Case Reports Journal|April 18, 2014
Magnetic resonance imaging features of brain and spinal cord injury in a fatal case of isopropanol intoxicationParag Suresh Mahajan, Joyal Jacob Mathew, Abhilash Pulincherry Jayaram, et al.Precision Radiation Oncology|January 1, 2026
Experimental design and control methods for dose rate optimization in a synchrotron-based proton therapy beamlineJason Tang, Daniel Liu, Jacob Mathew, et al.International Journal of Rheumatic Diseases|June 28, 2024
MRI predictors of infectious etiology in patients with unilateral sacroiliitisMadhavi Kandagaddala, Kirthi Sathyakumar, Ashish Jacob Mathew, et al.Tropical Doctor|May 6, 2025
Primary spontaneous colporrhexis in a primigravidaEunice Susanna Abraham, Ashwin Sukumar, Arpit Jacob Mathew, et al.The Annals of Thoracic Surgery|September 1, 2015
Forward Flow Through the Pulmonary Valve After Bidirectional Cavopulmonary Shunt Benefits Patients at Fontan OperationKoichi Sughimoto, Diana Zannino, Jacob Mathew, et al.Bioorganic Chemistry|October 2, 2023
Small molecule tractable PARP inhibitors: Scaffold construction approaches, mechanistic insights and structure activity relationshipAmandeep Thakur, Mandeep Rana, Ritika, et al.Journal of Clinical and Diagnostic Research : JCDR|May 19, 2016
Management of Chronic Periodontitis Using Chlorhexidine Chip and Diode Laser-A Clinical StudyKachapilly Arun Jose, Majo Ambooken, Jayan Jacob Mathew, et al.Journal of Drugs in Dermatology : JDD|August 2, 2024
Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque PsoriasisJayme Heim, J Gabriel Vasquez, Tina Bhutani, et al.Pageof 11